Popular Articles

Alzheimer's Disease: Disclosing Genetic Risk Does Not Cause Psychological Distress
Researchers from Boston University School of Medicine (BUSM) have shown that disclosing genetic risk information to adult children of patients with Alzheimer"s disease (AD) who request this information does not result in significant short-term psychological distress. The report from the REVEAL Study*, which appears in the July 16 issue of the New England Journal of Medicine, is the first randomized trial to disclose to participants whether or not they carried the íµ4 variant of the APOE gene, a variant that has been found to increase the risk of developing AD. The study demonstrated that test-related distress was reduced among those who learned that they were APOE íµ4 negative, and was only transiently increased among those who learned they were APOE íµ4 positive. The study also showed that persons with high levels of emotional distress before undergoing genetic testing were more likely to have emotional difficulties after disclosure.
generic viagra online
Women With Chest Pain Less Likely Then Men To Get Proper Treatment From Paramedics
Women with chest pain are less likely than male patients to receive recommended, proven therapies while en route to the hospital, according to new research from the University of Pennsylvania School of Medicine. Despite evidence showing that the drugs aspirin and nitroglycerin are important early interventions for people who may be having a heart attack, women don"t get them as often as male patients with the same types of symptoms, says a new study that will be presented Friday, May 15, 2009 at the Society for Academic Emergency Medicine"s annual conference.
News of the day
Impax Receives FDA Approval For Generic Precose(R) Tablets, 25 Mg, 50 Mg And 100 Mg
Impax Laboratories, Inc. (NASDAQ: IPXL) confirmed that the U.S. Food and Drug Administration (FDA) has granted approval of the Company"s Abbreviated New Drug Application (ANDA) for generic versions of Precose® Tablets (acarbose), 25 mg, 50 mg and 100 mg strengths. Precose®, a Bayer HealthCare Pharmaceuticals product, is used in the management of type two diabetes mellitus.
Endocrinology

Analysis: How Will $155 Billion Deal With White House Really Affect Hospitals?

When hospitals agreed to accept a $155 billion pay cut from the federal government to help Washington raise money for reform efforts earlier this month, it was "to the amazement of many," the Economist reports. "How can they justify giving away such a vast sum? There are several explanations, not all of them altruistic. Taken together, they show that the industry"s leaders are bracing themselves for a period of upheaval." Here are some motivating factors, according to the Economist: The industry will gain new customers from expanded access to health care, a chief goal of reform, the American Hospital Association says. Under the current system, hospitals treat lots of uninsured people who don"t pay their bills, netting around $34 billion in uncompensated care in 2007. Even though the government gives them money for some of this, they say that compensation fails to make them whole. "The huge sums the hospitals stand to gain from reducing such losses make even $155 billion over ten years look like a reasonable amount of money to sacrifice to secure such a bonanza," the Economist says. In addition, hospitals have sought to remain at the health reform negotiating table in hopes of thwarting plans for a new, government-run insurer they say would undercut their pricing and changes in the tax status of nonprofit hospitals that would cost many millions. Another "explicit concession wrung by the hospital bosses from the White House was a promise to crack down on clinics owned by doctors," which represent potential, unwanted competition for established hospitals. "As this back-room deal illustrates, the strongest motives behind the hospitals" ostensibly generous price cut were self-serving ones: to reduce competition, not boost it, and to head off any increase in government influence over their price," the Economist reports (7/16). Meanwhile, in Cook County, officials are complaining that health reform could harm Stroger Hospital, in Chicago, Chicago Public Radio reports. Its primary business is treating the uninsured and poor. "Those who have insurance don"t necessarily go to a safety net hospital," said Warren Batts, the chairman of the board that oversees Cook County"s health system. If that trend continues in a post-reform world, the hospital could see a 40 percent cut in the $85 million Washington pays them to treat the uninsured, with few gains of paying customers (Spitzer, 7/16). This information was reprinted from kaiserhealthnews.org with kind permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily Health Policy Report, search the archives and sign up for email delivery at kaiserhealthnews.org. © Henry J. Kaiser Family Foundation. All rights reserved.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):